captopril has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, LC; Chiou, J; Koohi-Moghadam, M; Kuang, X; Lam, TYC; Wen, C; Wu, H; Zhang, Y | 1 |
| Li, HB; Pepine, CJ; Raizada, MK; Richards, EM; Yang, T | 1 |
2 other study(ies) available for captopril and Disbacteriosis
| Article | Year |
|---|---|
Captopril Alleviates Chondrocyte Senescence in DOCA-Salt Hypertensive Rats Associated with Gut Microbiome Alteration.
Topics: Acetates; Animals; Antihypertensive Agents; Captopril; Chondrocytes; Desoxycorticosterone Acetate; Dysbiosis; Gastrointestinal Microbiome; Hypertension; Rats; RNA, Ribosomal, 16S | 2022 |
Maternal Treatment With Captopril Persistently Alters Gut-Brain Communication and Attenuates Hypertension of Male Offspring.
Topics: Animals; Antihypertensive Agents; Bacterial Proteins; Brain; Captopril; Colon; Dysbiosis; Female; Gastrointestinal Microbiome; Hypertension; Lactation; Male; Maternal-Fetal Exchange; Norepinephrine; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA; Sympathetic Nervous System; Tight Junction Proteins; Weaning | 2020 |